CATIP-AS2

Across TCGA pan-cancer cohorts, CATIP-AS2 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated CATIP-AS2 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CATIP-AS2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CATIP-AS2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and PRAD show a favorable association.

LUAD, LIHC, and LUSC are the cancer types where CATIP-AS2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.485	0.271	.006	44	view →
LIHC	OS	Median	All	0.429	0.582	.002	31	view →
LUSC	OS	Quartile	All	0.250	0.456	.003	21	view →
STAD	DFS	Median	III,IV	0.405	0.563	.013	18	view →
PRAD	DFS	Quartile	All	0.917	0.692	.007	14	view →
COAD	OS	Tertile	III,IV	0.541	0.780	.019	8	view →
READ	OS	Median	III,IV	1.000	0.735	.009	8	view →
BRCA	OS	Tertile	IV	0.685	0.266	.025	5	view →
TGCT	DFS	Median	All	0.784	0.560	.017	4	view →
OV	OS	Tertile	IV	0.325	0.571	.036	4	view →
LGG	DFS	Median	All	0.312	0.483	.009	4	view →
DLBC	DFS	Tertile	IV	1.000	0.479	.027	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

CATIP-AS2–LUAD (OS)

Open the LUAD breakdown →